CompletedNot Applicable

Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection

China60 participantsStarted 2022-04-01

Plain-language summary

This study aimed to evaluate whether vagus nerve-guided robotic-assisted splenectomy and azygoportal disconnection is effective and safe, and to determine whether a reduction in the incidence of postoperative complications of the digestive system improves postoperative quality of life compared with conventional robotic-assisted splenectomy and azygoportal disconnection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
✓. Splenomegaly with secondary hypersplenism
✓. Bleeding portal hypertension
✓. No evidence of portal vein system thrombosis by ultrasound evaluation and angio-CT
✓. Informed consent to participate in the study

Exclusion criteria

✕. Delayed gastric emptying
✕. Diarrhea
✕. Hepatocellular carcinoma or any other malignancy,
✕. Hypercoagulable state other than the liver disease related
✕. DRUGS- oral contraceptives, anticoagulation or anti-platelet drugs.
✕. Child - Pugh C
✕. Recent peptic ulcer disease
✕. History of Hemorrhagic stroke

What they're measuring

Diarrhea

Timeframe: 3 month

Delayed gastric emptying

Timeframe: 3 month

Trial details

NCT IDNCT05300516

SponsorNorthern Jiangsu People's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-31

View on ClinicalTrials.gov More Cirrhosis trials